<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02666794</url>
  </required_header>
  <id_info>
    <org_study_id>45992815000000068</org_study_id>
    <nct_id>NCT02666794</nct_id>
  </id_info>
  <brief_title>Trial on the Impact of Technical Anesthetic in Pregnancies With Intrauterine Growth Restriction</brief_title>
  <official_title>Comparative Clinical Trial on the Impact of Technical Anesthetic in Uterine Tone and Fetal Heart Rate in Pregnancies With Intrauterine Growth Restriction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The combined spinal-epidural analgesia during the labor has been associated with changes in
      fetal heart rate, which the opinions in literature are not fully consolidated and some
      studies have failed to show an increase significant fetal bradycardia following the
      combination lock. In addition, it's not clear that these changes found may modify the
      perinatal outcome in pregnancies who attend with intrauterine growth restriction (IUGR),
      since there are no studies comparing the techniques in this population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      INTRODUCTION: The combined spinal-epidural analgesia during labor has been associated with
      changes in fetal heart rate. Opinions in the literature are not fully consolidated, and some
      publications have failed to show a significant increase in fetal bradycardia following the
      combination lock. In addition, the question remains whether these changes found may modify
      the perinatal outcome in pregnancies that occur with intrauterine growth restriction (IUGR),
      since there are no studies comparing the techniques in this population.

      OBJECTIVES: To estimate the effects of combined spinal-epidural analgesia and epidural
      analgesia isolated on uterine basal tone and its association with the occurrence of changes
      in fetal heart rate on perinatal outcome in patients with fetuses with IUGR.

      METHOD: This is experimental, analytical, prospective, randomized, double-blind. It will
      include 74 pregnant women with gestations occurring with IUGR or chronic uteroplacental
      insufficiency of any etiology, that are still admitted to labor. Pregnant women will be
      randomly divided into two groups: combined spinal-epidural analgesia and epidural analgesia
      alone. The primary dependent variables to be evaluated will be the change in uterine tone and
      changes in the fetal heart rate.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 12, 2017</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fetal bradycardia</measure>
    <time_frame>45 minutes</time_frame>
    <description>Fetal bradycardia is defined as the baseline drops to less than 100 bpm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Increase in uterine tone</measure>
    <time_frame>45 minutes</time_frame>
    <description>Increase in uterine tone in 10 mmHg or more at baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal blood pressure</measure>
    <time_frame>45 minutes</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Pain scores</measure>
    <time_frame>45 minutes</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Apgar scores</measure>
    <time_frame>At birth</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Umbilical artery pH</measure>
    <time_frame>At birth</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Serum cathecolamines</measure>
    <time_frame>45 minutes</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Fetal Bradycardia</condition>
  <condition>Hypertonic Uterine</condition>
  <arm_group>
    <arm_group_label>Puncture epidural</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women in labor the epidural group will receive epidural bupivacaine with vasoconstrictor 0.125% 10 ml plus 10 micrograms sufentanil, followed by the placement of the epidural catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Puncture combined spinal-epidural</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The mothers of the combined spinal-epidural analgesia group will receive intrathecal hyperbaric bupivacaine solution 0.5% 2.5 mg plus 5.0 micrograms of sufentanil and plus 60 micrograms of morphine, followed by placement of an epidural catheter to the catheter through technical needle</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural bupivacaine with vasoconstrictor 0.125%</intervention_name>
    <description>10 ml</description>
    <arm_group_label>Puncture epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural sufentanil</intervention_name>
    <description>10 mcg</description>
    <arm_group_label>Puncture epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placement of the epidural catheter</intervention_name>
    <description>Placement of the epidural catheter</description>
    <arm_group_label>Puncture epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal hyperbaric bupivacaine solution 0.5%</intervention_name>
    <description>2.5 mg</description>
    <arm_group_label>Puncture combined spinal-epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal morphine</intervention_name>
    <description>60 mcg</description>
    <arm_group_label>Puncture combined spinal-epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placement of an epidural catheter to the catheter through technical needle</intervention_name>
    <description>Placement of an epidural catheter to the catheter through technical needle</description>
    <arm_group_label>Puncture combined spinal-epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal sufentanil</intervention_name>
    <description>5 mcg</description>
    <arm_group_label>Puncture combined spinal-epidural</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  previous diagnosis of intrauterine growth restriction

          -  maternal diseases that attend with chronic placental insufficiency (obesity, diabetes,
             arterial hypertension, kidney disease, thrombophilias, heart disease or lung disease)

        Exclusion Criteria:

          -  patients ASA I or IV

          -  contraindications regional analgesia

          -  prior use of systemic opioids for the relief of labor pain

          -  amniotic, and maternal infection

          -  known fetal diseases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shirley Santos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthesiologist</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shirley Santos, MD</last_name>
    <phone>5511985733798</phone>
    <email>shirleyandrade.s@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shirley Santos, MD</last_name>
    <email>shirleyandrade.s@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shirley Andrade Santos</name>
      <address>
        <city>SÃ£o Paulo</city>
        <zip>05408000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shirley Andrade Santos, M.D.</last_name>
      <phone>+5511985733798</phone>
      <email>shirleyandrade.s@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Baschat AA. Fetal growth restriction - from observation to intervention. J Perinat Med. 2010 May;38(3):239-46. doi: 10.1515/JPM.2010.041. Review.</citation>
    <PMID>20205623</PMID>
  </reference>
  <results_reference>
    <citation>AbrÃ£o KC, Francisco RP, Miyadahira S, Cicarelli DD, Zugaib M. Elevation of uterine basal tone and fetal heart rate abnormalities after labor analgesia: a randomized controlled trial. Obstet Gynecol. 2009 Jan;113(1):41-7. doi: 10.1097/AOG.0b013e31818f5eb6.</citation>
    <PMID>19104358</PMID>
  </results_reference>
  <results_reference>
    <citation>Van de Velde M, Vercauteren M, Vandermeersch E. Fetal heart rate abnormalities after regional analgesia for labor pain: the effect of intrathecal opioids. Reg Anesth Pain Med. 2001 May-Jun;26(3):257-62.</citation>
    <PMID>11359226</PMID>
  </results_reference>
  <results_reference>
    <citation>Nielsen PE, Erickson JR, Abouleish EI, Perriatt S, Sheppard C. Fetal heart rate changes after intrathecal sufentanil or epidural bupivacaine for labor analgesia: incidence and clinical significance. Anesth Analg. 1996 Oct;83(4):742-6.</citation>
    <PMID>8831313</PMID>
  </results_reference>
  <results_reference>
    <citation>Collis RE, Davies DW, Aveling W. Randomised comparison of combined spinal-epidural and standard epidural analgesia in labour. Lancet. 1995 Jun 3;345(8962):1413-6.</citation>
    <PMID>7760614</PMID>
  </results_reference>
  <results_reference>
    <citation>Nakamura G, Ganem EM, Rugolo LM, Castiglia YM. Effects on mother and fetus of epidural and combined spinal-epidural techniques for labor analgesia. Rev Assoc Med Bras (1992). 2009 Jul-Aug;55(4):405-9.</citation>
    <PMID>19750306</PMID>
  </results_reference>
  <results_reference>
    <citation>Patel NP, El-Wahab N, Fernando R, Wilson S, Robson SC, Columb MO, Lyons GR. Fetal effects of combined spinal-epidural vs epidural labour analgesia: a prospective, randomised double-blind study. Anaesthesia. 2014 May;69(5):458-67. doi: 10.1111/anae.12602.</citation>
    <PMID>24738803</PMID>
  </results_reference>
  <results_reference>
    <citation>Simmons SW, Taghizadeh N, Dennis AT, Hughes D, Cyna AM. Combined spinal-epidural versus epidural analgesia in labour. Cochrane Database Syst Rev. 2012 Oct 17;10:CD003401. doi: 10.1002/14651858.CD003401.pub3. Review.</citation>
    <PMID>23076897</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2015</study_first_submitted>
  <study_first_submitted_qc>January 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2016</study_first_posted>
  <last_update_submitted>July 20, 2017</last_update_submitted>
  <last_update_submitted_qc>July 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>SHIRLEY ANDRADE SANTOS</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>fetal bradycardia</keyword>
  <keyword>hypertonic uterine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
    <mesh_term>Fetal Growth Retardation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Vasoconstrictor Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

